Home
>
National Drug Code (NDC)
>
Coenzyme Compositum
Coenzyme Compositum - 50114-6141-5 - (BETA VULGARIS and ASCORBIC ACID and CYSTEINE and MAGNESIUM OROTATE and MANGANESE PHOSPHATE, DIBASIC and SODIUM DIETHYL OXALACETATE and NIACINAMIDE and PULSATILLA VULGARIS and PYRIDOXINE HYDROCHLORIDE and RIBOFLAVIN and THIAMINE HYDROCHLORIDE and .ALPHA.-LIPOIC ACID and .ALPHA.-KETOGLUTARIC ACID and CEROUS OXALATE NONAHYDRATE and ACONITIC ACID, (Z)- and ANHYDROUS CITRIC ACID and COENZYME A and FUMARIC ACID and MALIC ACID and NADIDE and SODIUM PYRUVATE and SUCCINIC ACID)
Drug Information of Coenzyme Compositum
| Product NDC: | 50114-6141 |
| Proprietary Name: | Coenzyme Compositum |
| Non Proprietary Name: | BETA VULGARIS and ASCORBIC ACID and CYSTEINE and MAGNESIUM OROTATE and MANGANESE PHOSPHATE, DIBASIC and SODIUM DIETHYL OXALACETATE and NIACINAMIDE and PULSATILLA VULGARIS and PYRIDOXINE HYDROCHLORIDE and RIBOFLAVIN and THIAMINE HYDROCHLORIDE and .ALPHA.-LIPOIC ACID and .ALPHA.-KETOGLUTARIC ACID and CEROUS OXALATE NONAHYDRATE and ACONITIC ACID, (Z)- and ANHYDROUS CITRIC ACID and COENZYME A and FUMARIC ACID and MALIC ACID and NADIDE and SODIUM PYRUVATE and SUCCINIC ACID |
| Active Ingredient(s): | 8; 6; 8; 10; 8; 6; 10; 4; 10; 8; 8; 6; 8; 6; 8; 6; 8; 6; 6; 6; 6; 6; 8; 8; 10; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; BETA VULGARIS and ASCORBIC ACID and CYSTEINE and MAGNESIUM OROTATE and MANGANESE PHOSPHATE, DIBASIC and SODIUM DIETHYL OXALACETATE and NIACINAMIDE and PULSATILLA VULGARIS and PYRIDOXINE HYDROCHLORIDE and RIBOFLAVIN and THIAMINE HYDROCHLORIDE and .ALPHA.-LIPOIC ACID and .ALPHA.-KETOGLUTARIC ACID and CEROUS OXALATE NONAHYDRATE and ACONITIC ACID, (Z)- and ANHYDROUS CITRIC ACID and COENZYME A and FUMARIC ACID and MALIC ACID and NADIDE and SODIUM PYRUVATE and SUCCINIC ACID |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Coenzyme Compositum
| Product NDC: | 50114-6141 |
| Labeler Name: | Heel Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20030831 |
Package Information of Coenzyme Compositum
| Package NDC: | 50114-6141-5 |
| Package Description: | 15 TABLET in 1 BOTTLE (50114-6141-5) |
NDC Information of Coenzyme Compositum
| NDC Code | 50114-6141-5 |
| Proprietary Name | Coenzyme Compositum |
| Package Description | 15 TABLET in 1 BOTTLE (50114-6141-5) |
| Product NDC | 50114-6141 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | BETA VULGARIS and ASCORBIC ACID and CYSTEINE and MAGNESIUM OROTATE and MANGANESE PHOSPHATE, DIBASIC and SODIUM DIETHYL OXALACETATE and NIACINAMIDE and PULSATILLA VULGARIS and PYRIDOXINE HYDROCHLORIDE and RIBOFLAVIN and THIAMINE HYDROCHLORIDE and .ALPHA.-LIPOIC ACID and .ALPHA.-KETOGLUTARIC ACID and CEROUS OXALATE NONAHYDRATE and ACONITIC ACID, (Z)- and ANHYDROUS CITRIC ACID and COENZYME A and FUMARIC ACID and MALIC ACID and NADIDE and SODIUM PYRUVATE and SUCCINIC ACID |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20030831 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Heel Inc |
| Substance Name | .ALPHA.-KETOGLUTARIC ACID; .ALPHA.-LIPOIC ACID; ACONITIC ACID, (Z)-; ADENOSINE TRIPHOSPHATE; ANHYDROUS CITRIC ACID; ASCORBIC ACID; BARIUM OXALOSUCCINATE; BETA VULGARIS; CALCIUM SULFIDE; CEROUS OXALATE NONAHYDRATE; COENZYME A; CYSTEINE; FUMARIC ACID; MAGNESIUM OROTATE; MALIC ACID; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NIACINAMIDE; PULSATILLA VULGARIS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE HYDROCHLORIDE |
| Strength Number | 8; 6; 8; 10; 8; 6; 10; 4; 10; 8; 8; 6; 8; 6; 8; 6; 8; 6; 6; 6; 6; 6; 8; 8; 10; 6 |
| Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Pharmaceutical Classes |
